Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy Male Volunteers who are ≥19 years old~* Body weight ≥50.0 kg and BMI between 18.0 and 30.0 kg/m2 and~Exclusion Criteria:~* Clinically significant Medical History

- Gender: MALE
- Minimum Age: 19 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Sequence A (Type: EXPERIMENTAL): cross-over
- Sequence B (Type: EXPERIMENTAL): cross-over

Based on this trial design, predict the completion outcome and termination type (if applicable).